Celldex Therapeutics, Inc. (CLDX): Weighted Average Diluted Shares
66.42M
Year ended 2025-12-31
n/m
3-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 66.42M | +3.1% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | 64.39M | +32.9% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | 48.45M | n/m | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | 46.9K | +9.4% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | 42.9K | n/c | 2024-02-26, From 2021-01-01 |
| 2020-12-31 | 29.6K | n/c | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | 14.5K | n/a | 2022-02-28, From 2019-01-01 |
| No annual figure between 2011-12-31 and 2019-12-31. | |||
| 2011-12-31 | 39.50M | +24.0% | 2012-03-08, From 2011-01-01 |
| 2010-12-31 | 31.87M | +60.8% | 2012-03-08, From 2010-01-01 |
| 2009-12-31 | 19.82M | n/a | 2012-03-08, From 2009-01-01 |